Global SPECT and PET Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Description

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global SPECT and PET Radiopharmaceuticals market size is expected to reach $ 10510 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

This report studies the global SPECT and PET Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for SPECT and PET Radiopharmaceuticals and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of SPECT and PET Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global SPECT and PET Radiopharmaceuticals total production and demand, 2019-2030, (K Dose)
Global SPECT and PET Radiopharmaceuticals total production value, 2019-2030, (USD Million)
Global SPECT and PET Radiopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Dose), (based on production site)
Global SPECT and PET Radiopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K Dose)
U.S. VS China: SPECT and PET Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global SPECT and PET Radiopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Dose)
Global SPECT and PET Radiopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global SPECT and PET Radiopharmaceuticals production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
This report profiles key players in the global SPECT and PET Radiopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World SPECT and PET Radiopharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global SPECT and PET Radiopharmaceuticals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global SPECT and PET Radiopharmaceuticals Market, Segmentation by Type:
    Diagnostic Radiopharmaceuticals
    Therapeutic Radiopharmaceuticals

Global SPECT and PET Radiopharmaceuticals Market, Segmentation by Application:
    Hospitals
    Clinics
    Others

Companies Profiled:
    Cardinal Health
    GE Healthcare
    Jubilant Pharma
    Novartis
    Curium Pharma
    SIEMENS
    Lantheus
    Bracco Imaging
    Bayer
    Eli Lilly
    Aurobindo Pharma
    Mundipharma
    China Isotope & Radiation
    Dongcheng

Key Questions Answered:
1. How big is the global SPECT and PET Radiopharmaceuticals market?
2. What is the demand of the global SPECT and PET Radiopharmaceuticals market?
3. What is the year over year growth of the global SPECT and PET Radiopharmaceuticals market?
4. What is the production and production value of the global SPECT and PET Radiopharmaceuticals market?
5. Who are the key producers in the global SPECT and PET Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 SPECT and PET Radiopharmaceuticals Introduction
    1.2 World SPECT and PET Radiopharmaceuticals Supply & Forecast
        1.2.1 World SPECT and PET Radiopharmaceuticals Production Value (2019 & 2023 & 2030)
        1.2.2 World SPECT and PET Radiopharmaceuticals Production (2019-2030)
        1.2.3 World SPECT and PET Radiopharmaceuticals Pricing Trends (2019-2030)
    1.3 World SPECT and PET Radiopharmaceuticals Production by Region (Based on Production Site)
        1.3.1 World SPECT and PET Radiopharmaceuticals Production Value by Region (2019-2030)
        1.3.2 World SPECT and PET Radiopharmaceuticals Production by Region (2019-2030)
        1.3.3 World SPECT and PET Radiopharmaceuticals Average Price by Region (2019-2030)
        1.3.4 North America SPECT and PET Radiopharmaceuticals Production (2019-2030)
        1.3.5 Europe SPECT and PET Radiopharmaceuticals Production (2019-2030)
        1.3.6 China SPECT and PET Radiopharmaceuticals Production (2019-2030)
        1.3.7 Japan SPECT and PET Radiopharmaceuticals Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 SPECT and PET Radiopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 SPECT and PET Radiopharmaceuticals Major Market Trends

2 Demand Summary
    2.1 World SPECT and PET Radiopharmaceuticals Demand (2019-2030)
    2.2 World SPECT and PET Radiopharmaceuticals Consumption by Region
        2.2.1 World SPECT and PET Radiopharmaceuticals Consumption by Region (2019-2024)
        2.2.2 World SPECT and PET Radiopharmaceuticals Consumption Forecast by Region (2025-2030)
    2.3 United States SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.4 China SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.5 Europe SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.6 Japan SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.7 South Korea SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.8 ASEAN SPECT and PET Radiopharmaceuticals Consumption (2019-2030)
    2.9 India SPECT and PET Radiopharmaceuticals Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World SPECT and PET Radiopharmaceuticals Production Value by Manufacturer (2019-2024)
    3.2 World SPECT and PET Radiopharmaceuticals Production by Manufacturer (2019-2024)
    3.3 World SPECT and PET Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
    3.4 SPECT and PET Radiopharmaceuticals Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global SPECT and PET Radiopharmaceuticals Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for SPECT and PET Radiopharmaceuticals in 2023
        3.5.3 Global Concentration Ratios (CR8) for SPECT and PET Radiopharmaceuticals in 2023
    3.6 SPECT and PET Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.6.1 SPECT and PET Radiopharmaceuticals Market: Region Footprint
        3.6.2 SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
        3.6.3 SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: SPECT and PET Radiopharmaceuticals Production Value Comparison
        4.1.1 United States VS China: SPECT and PET Radiopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: SPECT and PET Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: SPECT and PET Radiopharmaceuticals Production Comparison
        4.2.1 United States VS China: SPECT and PET Radiopharmaceuticals Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: SPECT and PET Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: SPECT and PET Radiopharmaceuticals Consumption Comparison
        4.3.1 United States VS China: SPECT and PET Radiopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: SPECT and PET Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based SPECT and PET Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value (2019-2024)
        4.4.3 United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production (2019-2024)
    4.5 China Based SPECT and PET Radiopharmaceuticals Manufacturers and Market Share
        4.5.1 China Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value (2019-2024)
        4.5.3 China Based Manufacturers SPECT and PET Radiopharmaceuticals Production (2019-2024)
    4.6 Rest of World Based SPECT and PET Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
    5.1 World SPECT and PET Radiopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Diagnostic Radiopharmaceuticals
        5.2.2 Therapeutic Radiopharmaceuticals
    5.3 Market Segment by Type
        5.3.1 World SPECT and PET Radiopharmaceuticals Production by Type (2019-2030)
        5.3.2 World SPECT and PET Radiopharmaceuticals Production Value by Type (2019-2030)
        5.3.3 World SPECT and PET Radiopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World SPECT and PET Radiopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World SPECT and PET Radiopharmaceuticals Production by Application (2019-2030)
        6.3.2 World SPECT and PET Radiopharmaceuticals Production Value by Application (2019-2030)
        6.3.3 World SPECT and PET Radiopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Cardinal Health
        7.1.1 Cardinal Health Details
        7.1.2 Cardinal Health Major Business
        7.1.3 Cardinal Health SPECT and PET Radiopharmaceuticals Product and Services
        7.1.4 Cardinal Health SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Cardinal Health Recent Developments/Updates
        7.1.6 Cardinal Health Competitive Strengths & Weaknesses
    7.2 GE Healthcare
        7.2.1 GE Healthcare Details
        7.2.2 GE Healthcare Major Business
        7.2.3 GE Healthcare SPECT and PET Radiopharmaceuticals Product and Services
        7.2.4 GE Healthcare SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 GE Healthcare Recent Developments/Updates
        7.2.6 GE Healthcare Competitive Strengths & Weaknesses
    7.3 Jubilant Pharma
        7.3.1 Jubilant Pharma Details
        7.3.2 Jubilant Pharma Major Business
        7.3.3 Jubilant Pharma SPECT and PET Radiopharmaceuticals Product and Services
        7.3.4 Jubilant Pharma SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Jubilant Pharma Recent Developments/Updates
        7.3.6 Jubilant Pharma Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis SPECT and PET Radiopharmaceuticals Product and Services
        7.4.4 Novartis SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Curium Pharma
        7.5.1 Curium Pharma Details
        7.5.2 Curium Pharma Major Business
        7.5.3 Curium Pharma SPECT and PET Radiopharmaceuticals Product and Services
        7.5.4 Curium Pharma SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Curium Pharma Recent Developments/Updates
        7.5.6 Curium Pharma Competitive Strengths & Weaknesses
    7.6 SIEMENS
        7.6.1 SIEMENS Details
        7.6.2 SIEMENS Major Business
        7.6.3 SIEMENS SPECT and PET Radiopharmaceuticals Product and Services
        7.6.4 SIEMENS SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 SIEMENS Recent Developments/Updates
        7.6.6 SIEMENS Competitive Strengths & Weaknesses
    7.7 Lantheus
        7.7.1 Lantheus Details
        7.7.2 Lantheus Major Business
        7.7.3 Lantheus SPECT and PET Radiopharmaceuticals Product and Services
        7.7.4 Lantheus SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Lantheus Recent Developments/Updates
        7.7.6 Lantheus Competitive Strengths & Weaknesses
    7.8 Bracco Imaging
        7.8.1 Bracco Imaging Details
        7.8.2 Bracco Imaging Major Business
        7.8.3 Bracco Imaging SPECT and PET Radiopharmaceuticals Product and Services
        7.8.4 Bracco Imaging SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Bracco Imaging Recent Developments/Updates
        7.8.6 Bracco Imaging Competitive Strengths & Weaknesses
    7.9 Bayer
        7.9.1 Bayer Details
        7.9.2 Bayer Major Business
        7.9.3 Bayer SPECT and PET Radiopharmaceuticals Product and Services
        7.9.4 Bayer SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Bayer Recent Developments/Updates
        7.9.6 Bayer Competitive Strengths & Weaknesses
    7.10 Eli Lilly
        7.10.1 Eli Lilly Details
        7.10.2 Eli Lilly Major Business
        7.10.3 Eli Lilly SPECT and PET Radiopharmaceuticals Product and Services
        7.10.4 Eli Lilly SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Eli Lilly Recent Developments/Updates
        7.10.6 Eli Lilly Competitive Strengths & Weaknesses
    7.11 Aurobindo Pharma
        7.11.1 Aurobindo Pharma Details
        7.11.2 Aurobindo Pharma Major Business
        7.11.3 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product and Services
        7.11.4 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Aurobindo Pharma Recent Developments/Updates
        7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
    7.12 Mundipharma
        7.12.1 Mundipharma Details
        7.12.2 Mundipharma Major Business
        7.12.3 Mundipharma SPECT and PET Radiopharmaceuticals Product and Services
        7.12.4 Mundipharma SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Mundipharma Recent Developments/Updates
        7.12.6 Mundipharma Competitive Strengths & Weaknesses
    7.13 China Isotope & Radiation
        7.13.1 China Isotope & Radiation Details
        7.13.2 China Isotope & Radiation Major Business
        7.13.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Services
        7.13.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 China Isotope & Radiation Recent Developments/Updates
        7.13.6 China Isotope & Radiation Competitive Strengths & Weaknesses
    7.14 Dongcheng
        7.14.1 Dongcheng Details
        7.14.2 Dongcheng Major Business
        7.14.3 Dongcheng SPECT and PET Radiopharmaceuticals Product and Services
        7.14.4 Dongcheng SPECT and PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Dongcheng Recent Developments/Updates
        7.14.6 Dongcheng Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 SPECT and PET Radiopharmaceuticals Industry Chain
    8.2 SPECT and PET Radiopharmaceuticals Upstream Analysis
        8.2.1 SPECT and PET Radiopharmaceuticals Core Raw Materials
        8.2.2 Main Manufacturers of SPECT and PET Radiopharmaceuticals Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 SPECT and PET Radiopharmaceuticals Production Mode
    8.6 SPECT and PET Radiopharmaceuticals Procurement Model
    8.7 SPECT and PET Radiopharmaceuticals Industry Sales Model and Sales Channels
        8.7.1 SPECT and PET Radiopharmaceuticals Sales Model
        8.7.2 SPECT and PET Radiopharmaceuticals Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World SPECT and PET Radiopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World SPECT and PET Radiopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
 Table 3. World SPECT and PET Radiopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
 Table 4. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Region (2019-2024)
 Table 5. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Region (2025-2030)
 Table 6. World SPECT and PET Radiopharmaceuticals Production by Region (2019-2024) & (K Dose)
 Table 7. World SPECT and PET Radiopharmaceuticals Production by Region (2025-2030) & (K Dose)
 Table 8. World SPECT and PET Radiopharmaceuticals Production Market Share by Region (2019-2024)
 Table 9. World SPECT and PET Radiopharmaceuticals Production Market Share by Region (2025-2030)
 Table 10. World SPECT and PET Radiopharmaceuticals Average Price by Region (2019-2024) & (US$/Dose)
 Table 11. World SPECT and PET Radiopharmaceuticals Average Price by Region (2025-2030) & (US$/Dose)
 Table 12. SPECT and PET Radiopharmaceuticals Major Market Trends
 Table 13. World SPECT and PET Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Dose)
 Table 14. World SPECT and PET Radiopharmaceuticals Consumption by Region (2019-2024) & (K Dose)
 Table 15. World SPECT and PET Radiopharmaceuticals Consumption Forecast by Region (2025-2030) & (K Dose)
 Table 16. World SPECT and PET Radiopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key SPECT and PET Radiopharmaceuticals Producers in 2023
 Table 18. World SPECT and PET Radiopharmaceuticals Production by Manufacturer (2019-2024) & (K Dose)
 Table 19. Production Market Share of Key SPECT and PET Radiopharmaceuticals Producers in 2023
 Table 20. World SPECT and PET Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 21. Global SPECT and PET Radiopharmaceuticals Company Evaluation Quadrant
 Table 22. World SPECT and PET Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and SPECT and PET Radiopharmaceuticals Production Site of Key Manufacturer
 Table 24. SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
 Table 25. SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
 Table 26. SPECT and PET Radiopharmaceuticals Competitive Factors
 Table 27. SPECT and PET Radiopharmaceuticals New Entrant and Capacity Expansion Plans
 Table 28. SPECT and PET Radiopharmaceuticals Mergers & Acquisitions Activity
 Table 29. United States VS China SPECT and PET Radiopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China SPECT and PET Radiopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K Dose)
 Table 31. United States VS China SPECT and PET Radiopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K Dose)
 Table 32. United States Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production (2019-2024) & (K Dose)
 Table 36. United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share (2019-2024)
 Table 37. China Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers SPECT and PET Radiopharmaceuticals Production, (2019-2024) & (K Dose)
 Table 41. China Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share (2019-2024)
 Table 42. Rest of World Based SPECT and PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production, (2019-2024) & (K Dose)
 Table 46. Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share (2019-2024)
 Table 47. World SPECT and PET Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World SPECT and PET Radiopharmaceuticals Production by Type (2019-2024) & (K Dose)
 Table 49. World SPECT and PET Radiopharmaceuticals Production by Type (2025-2030) & (K Dose)
 Table 50. World SPECT and PET Radiopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
 Table 51. World SPECT and PET Radiopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
 Table 52. World SPECT and PET Radiopharmaceuticals Average Price by Type (2019-2024) & (US$/Dose)
 Table 53. World SPECT and PET Radiopharmaceuticals Average Price by Type (2025-2030) & (US$/Dose)
 Table 54. World SPECT and PET Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World SPECT and PET Radiopharmaceuticals Production by Application (2019-2024) & (K Dose)
 Table 56. World SPECT and PET Radiopharmaceuticals Production by Application (2025-2030) & (K Dose)
 Table 57. World SPECT and PET Radiopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
 Table 58. World SPECT and PET Radiopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
 Table 59. World SPECT and PET Radiopharmaceuticals Average Price by Application (2019-2024) & (US$/Dose)
 Table 60. World SPECT and PET Radiopharmaceuticals Average Price by Application (2025-2030) & (US$/Dose)
 Table 61. Cardinal Health Basic Information, Manufacturing Base and Competitors
 Table 62. Cardinal Health Major Business
 Table 63. Cardinal Health SPECT and PET Radiopharmaceuticals Product and Services
 Table 64. Cardinal Health SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Cardinal Health Recent Developments/Updates
 Table 66. Cardinal Health Competitive Strengths & Weaknesses
 Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
 Table 68. GE Healthcare Major Business
 Table 69. GE Healthcare SPECT and PET Radiopharmaceuticals Product and Services
 Table 70. GE Healthcare SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. GE Healthcare Recent Developments/Updates
 Table 72. GE Healthcare Competitive Strengths & Weaknesses
 Table 73. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
 Table 74. Jubilant Pharma Major Business
 Table 75. Jubilant Pharma SPECT and PET Radiopharmaceuticals Product and Services
 Table 76. Jubilant Pharma SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Jubilant Pharma Recent Developments/Updates
 Table 78. Jubilant Pharma Competitive Strengths & Weaknesses
 Table 79. Novartis Basic Information, Manufacturing Base and Competitors
 Table 80. Novartis Major Business
 Table 81. Novartis SPECT and PET Radiopharmaceuticals Product and Services
 Table 82. Novartis SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Novartis Recent Developments/Updates
 Table 84. Novartis Competitive Strengths & Weaknesses
 Table 85. Curium Pharma Basic Information, Manufacturing Base and Competitors
 Table 86. Curium Pharma Major Business
 Table 87. Curium Pharma SPECT and PET Radiopharmaceuticals Product and Services
 Table 88. Curium Pharma SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Curium Pharma Recent Developments/Updates
 Table 90. Curium Pharma Competitive Strengths & Weaknesses
 Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
 Table 92. SIEMENS Major Business
 Table 93. SIEMENS SPECT and PET Radiopharmaceuticals Product and Services
 Table 94. SIEMENS SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. SIEMENS Recent Developments/Updates
 Table 96. SIEMENS Competitive Strengths & Weaknesses
 Table 97. Lantheus Basic Information, Manufacturing Base and Competitors
 Table 98. Lantheus Major Business
 Table 99. Lantheus SPECT and PET Radiopharmaceuticals Product and Services
 Table 100. Lantheus SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Lantheus Recent Developments/Updates
 Table 102. Lantheus Competitive Strengths & Weaknesses
 Table 103. Bracco Imaging Basic Information, Manufacturing Base and Competitors
 Table 104. Bracco Imaging Major Business
 Table 105. Bracco Imaging SPECT and PET Radiopharmaceuticals Product and Services
 Table 106. Bracco Imaging SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Bracco Imaging Recent Developments/Updates
 Table 108. Bracco Imaging Competitive Strengths & Weaknesses
 Table 109. Bayer Basic Information, Manufacturing Base and Competitors
 Table 110. Bayer Major Business
 Table 111. Bayer SPECT and PET Radiopharmaceuticals Product and Services
 Table 112. Bayer SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Bayer Recent Developments/Updates
 Table 114. Bayer Competitive Strengths & Weaknesses
 Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 116. Eli Lilly Major Business
 Table 117. Eli Lilly SPECT and PET Radiopharmaceuticals Product and Services
 Table 118. Eli Lilly SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Eli Lilly Recent Developments/Updates
 Table 120. Eli Lilly Competitive Strengths & Weaknesses
 Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
 Table 122. Aurobindo Pharma Major Business
 Table 123. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product and Services
 Table 124. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Aurobindo Pharma Recent Developments/Updates
 Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
 Table 127. Mundipharma Basic Information, Manufacturing Base and Competitors
 Table 128. Mundipharma Major Business
 Table 129. Mundipharma SPECT and PET Radiopharmaceuticals Product and Services
 Table 130. Mundipharma SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Mundipharma Recent Developments/Updates
 Table 132. Mundipharma Competitive Strengths & Weaknesses
 Table 133. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
 Table 134. China Isotope & Radiation Major Business
 Table 135. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Services
 Table 136. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. China Isotope & Radiation Recent Developments/Updates
 Table 138. China Isotope & Radiation Competitive Strengths & Weaknesses
 Table 139. Dongcheng Basic Information, Manufacturing Base and Competitors
 Table 140. Dongcheng Major Business
 Table 141. Dongcheng SPECT and PET Radiopharmaceuticals Product and Services
 Table 142. Dongcheng SPECT and PET Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Dongcheng Recent Developments/Updates
 Table 144. Dongcheng Competitive Strengths & Weaknesses
 Table 145. Global Key Players of SPECT and PET Radiopharmaceuticals Upstream (Raw Materials)
 Table 146. Global SPECT and PET Radiopharmaceuticals Typical Customers
 Table 147. SPECT and PET Radiopharmaceuticals Typical Distributors


List of Figures
 Figure 1. SPECT and PET Radiopharmaceuticals Picture
 Figure 2. World SPECT and PET Radiopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World SPECT and PET Radiopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World SPECT and PET Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 5. World SPECT and PET Radiopharmaceuticals Average Price (2019-2030) & (US$/Dose)
 Figure 6. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Region (2019-2030)
 Figure 7. World SPECT and PET Radiopharmaceuticals Production Market Share by Region (2019-2030)
 Figure 8. North America SPECT and PET Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 9. Europe SPECT and PET Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 10. China SPECT and PET Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 11. Japan SPECT and PET Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 12. SPECT and PET Radiopharmaceuticals Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 15. World SPECT and PET Radiopharmaceuticals Consumption Market Share by Region (2019-2030)
 Figure 16. United States SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 17. China SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 18. Europe SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 19. Japan SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 20. South Korea SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 21. ASEAN SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 22. India SPECT and PET Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 23. Producer Shipments of SPECT and PET Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for SPECT and PET Radiopharmaceuticals Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for SPECT and PET Radiopharmaceuticals Markets in 2023
 Figure 26. United States VS China: SPECT and PET Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: SPECT and PET Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: SPECT and PET Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share 2023
 Figure 30. China Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers SPECT and PET Radiopharmaceuticals Production Market Share 2023
 Figure 32. World SPECT and PET Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Type in 2023
 Figure 34. Diagnostic Radiopharmaceuticals
 Figure 35. Therapeutic Radiopharmaceuticals
 Figure 36. World SPECT and PET Radiopharmaceuticals Production Market Share by Type (2019-2030)
 Figure 37. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Type (2019-2030)
 Figure 38. World SPECT and PET Radiopharmaceuticals Average Price by Type (2019-2030) & (US$/Dose)
 Figure 39. World SPECT and PET Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Application in 2023
 Figure 41. Hospitals
 Figure 42. Clinics
 Figure 43. Others
 Figure 44. World SPECT and PET Radiopharmaceuticals Production Market Share by Application (2019-2030)
 Figure 45. World SPECT and PET Radiopharmaceuticals Production Value Market Share by Application (2019-2030)
 Figure 46. World SPECT and PET Radiopharmaceuticals Average Price by Application (2019-2030) & (US$/Dose)
 Figure 47. SPECT and PET Radiopharmaceuticals Industry Chain
 Figure 48. SPECT and PET Radiopharmaceuticals Procurement Model
 Figure 49. SPECT and PET Radiopharmaceuticals Sales Model
 Figure 50. SPECT and PET Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Companies Mentioned

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng